Gregory Hapgood

15PUBLICATIONS
111CO-AUTHORS
Humoural immunology and immunochemistryHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Animal immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 04, 2026
Low tumor burden follicular lymphoma: The state of the art.

|Sep 20, 2026
Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

|Aug 27, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Sep 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

|Feb 13, 2025
An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular Lymphoma.

Daniel Erku, Joshua W D Tobin, John F Seymour

Pageof 3

Frequent Collaborators

6 joint publications

Eliza Hawkes

4 joint publications

Judith Trotman

4 joint publications

Matthew Ku

4 joint publications

Michael Dickinson